BeStock  
Stocks › Gene Editing › BEAM

Beam Therapeutics BEAM

US equityMarket cap rank #2634AI medical concept stocksGene Editing
$20.90 −$0.04 (-0.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $21.66 +3.65%
Open$20.60
Prev close$20.94
Day range$20.54 – $22.10
Volume3.89M
Market cap$2.16B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$307,000.00-96.8% YoY
Operating profit-$141.32M-11.4% YoY
Net profit-$134.41M-19.4% YoY
Diluted EPS-$1.28-16.4% YoY
Free cash flow-$111.96M-29.4% YoY
Operating cash flow-$110.75M

Revenue, last 8 quarters

$30.1MDec '24$7.5MMar '25$8.5MJun '25$9.7MSep '25$114.1MDec '25$31.7MMar '26$490.0KJun '26$307.0KSep '26

Net profit, last 8 quarters

$-90.4MDec '24$-108.3MMar '25$-102.1MJun '25$-112.6MSep '25$243.0MDec '25$-94.3MMar '26$-122.7MJun '26$-134.4MSep '26

Diluted EPS by quarter

-1.09Dec '24-1.23Mar '25-1.00Jun '25-1.10Sep '252.33Dec '25-0.91Mar '26-1.18Jun '26-1.28Sep '26

Free cash flow by quarter

$-79.3MDec '24$-106.9MMar '25$-79.6MJun '25$-86.5MSep '25$-87.0MDec '25$-130.7MMar '26$-68.5MJun '26$-112.0MSep '26

Annual revenue

$24.0KFY20$51.8MFY21$60.9MFY22$377.7MFY23$63.5MFY24$139.7MFY25

Profitability & balance sheet

Operating margin-267.7%
Net margin-73.9%
Return on equity-11.3%
Return on assets-8.4%
Return on invested capital-9.4%
Current ratio13.00
Liabilities / assets24.9%
Cash & investments$1.04B
Total debt$228.23M
Net cash (debt)$815.65M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $307,000.00 $490,000.00 $31.74M $139.74M $114.11M
Total Operating Revenue $307,000.00 $490,000.00 $31.74M $139.74M $114.11M
Operating Expense $141.63M $127.04M $138.95M $523.44M $131.55M
Selling and Admin Expenses $31.52M $31.95M $34.43M $113.82M $32.28M
-General & Admin Expense $31.52M $31.95M $34.43M $113.82M $32.28M
Research & Development $110.11M $95.10M $104.52M $409.62M $99.28M
Operating Profit -$141.32M -$126.55M -$107.22M -$383.69M -$17.45M
Net Non-Operating Interest Income (Expense) $6.09M $7.49M $9.87M $43.73M $10.64M
Total Other Finance Costs -$6.09M -$7.49M -$9.87M -$43.73M -$10.64M
Other Income (Expense) $823,000.00 -$4.07M $3.03M $259.97M $249.85M
Gain on Sale of Security $3.68M -$3.86M $2.52M $4.64M -$4.53M
Special Income (Charges) -$2.86M -$205,000.00 $514,000.00 $180,000.00 -$765,000.00
-Less:Restructuring and Mergern & Acquisition $2.86M $205,000.00 -$514,000.00 -$180,000.00 $765,000.00
Pretax Profit -$134.41M -$123.13M -$94.32M -$79.99M $243.05M
$0.00 – – – –
Net Profit -$134.41M -$122.68M -$94.32M -$79.99M $243.05M
Profit from Continuing Operations -$134.41M -$122.68M -$94.32M -$79.99M $243.05M
Net Income to Parent Company -$134.41M -$122.68M -$94.32M -$79.99M $243.05M
Net Income to Common Stockholders -$134.41M -$122.68M -$94.32M -$79.99M $243.05M
Basic EPS -$1.28 -$1.18 -$0.91 -$0.81 $2.37
Diluted EPS -$1.28 -$1.18 -$0.91 -$0.81 $2.33
Tax – -$455,000.00 – $0.00 $0.00
Earnings from Equity Interest – – – $255.15M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.27B $1.39B $1.48B $1.48B $1.48B
Total Current Assets $1.07B $1.18B $1.27B $1.27B $1.27B
Cash and Cash Equivalents & Short-Term Investments $1.04B $1.15B $1.21B $1.25B $1.25B
-Cash and Cash Equivalents $213.27M $219.83M $288.29M $294.94M $294.94M
-Short Term Investments $830.61M $933.10M $923.36M $950.27M $950.27M
Other Current Assets $23.50M $25.67M $55.30M $23.48M $23.48M
Total Non-Current Assets $201.70M $207.76M $213.85M $212.49M $212.49M
Net PPE $187.03M $193.19M $199.40M $205.18M $205.18M
-Gross PPE $297.20M $298.00M $299.13M $299.31M $299.31M
-Accumulated Depreciation -$110.17M -$104.81M -$99.73M -$94.13M -$94.13M
Other Non-Current Assets $14.66M $14.57M $14.45M $7.31M $7.31M
Total Liabilities $316.40M $318.91M $316.36M $242.82M $242.82M
Total Current Liabilities $82.08M $80.88M $74.57M $96.94M $96.94M
Payables $20.15M $13.10M $12.29M $10.23M $10.23M
-Accounts Payable $20.15M $13.10M $12.29M $10.23M $10.23M
Current Accrued Expenses $16.17M $17.28M $23.46M $23.94M $23.94M
Short-Term Debt and Capital Lease Obligation $15.65M $15.21M $14.78M $14.36M $14.36M
-Current Capital Lease Obligation $15.65M $15.21M $14.78M $14.36M $14.36M
Current Deferred Liabilities $0.00 $0.00 $304,000.00 $6.66M $6.66M
Other Current Liabilities $11.25M $21.23M $17.06M $12.40M $12.40M
Total Non-Current Liabilities $234.32M $238.03M $241.80M $145.88M $145.88M
Long Term Debt and Capital Lease Obligation $228.23M $232.15M $236.04M $139.76M $139.76M
-Long Term Debt $100.36M $100.26M $100.19M – –
-Long Term Capital Lease Obligation $127.86M $131.89M $135.85M $139.76M $139.76M
Other Non-Current Liabilities $6.10M $5.88M $5.75M $6.13M $6.13M
Total Equity $952.67M $1.07B $1.16B $1.24B $1.24B
Stockholders' Equity $952.67M $1.07B $1.16B $1.24B $1.24B
Capital Stock $1.03M $1.03M $1.03M $1.02M $1.02M
-Common Stock $1.03M $1.03M $1.03M $1.02M $1.02M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.95B $2.93B $2.90B $2.88B $2.88B
Retained Earnings -$1.99B -$1.86B -$1.74B -$1.64B -$1.64B
Gains/Losses Not Affecting Retained Earnings -$3.43M -$2.19M -$1.07M $1.11M $1.11M
Derivative Product Liabilities – – – $0.00 $0.00
Non-Current Deferred Liabilities – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$110.75M -$66.10M -$128.51M -$345.10M -$83.29M
Net cash flow from continuing operations -$110.75M -$66.10M -$128.51M -$345.10M -$83.29M
Net Income from Continuing Operations -$134.41M -$122.68M -$94.32M -$79.99M $243.05M
Gain/Loss from Continuing Operations -$4.70M $3.79M -$2.50M -$255.45M -$253.95M
Depreciation & Depletion & Amortization $5.45M $5.41M $5.61M $22.29M $5.67M
Other Non-Cash Items $5.56M $2.83M $2.05M $24.72M $3.28M
Change in Working Capital $620,000.00 $28.22M -$55.62M -$131.02M -$101.86M
-Change in Prepaid Assets $2.07M $29.53M -$31.86M $4.51M $59,000.00
-Change in Payables and Accrued Expense $2.07M $2.53M -$14.04M $13.73M $15.49M
-Change in Other Current Liabilities -$3.52M -$3.54M -$3.36M -$13.84M -$3.59M
-Change In Other Working Capital $0.00 -$304,000.00 -$6.36M -$135.42M -$113.82M
Net cash flow from investing $101.86M -$9.88M $25.27M -$121.44M $108.41M
Net Cash Flow from Continuing Investing Activities $101.86M -$9.88M $25.27M -$121.44M $108.41M
Net PPE Purchase and Sale -$1.21M -$2.41M -$2.23M -$14.95M -$3.73M
Net Business Purchase and Sale $0.00 – – $255.07M $255.15M
Net Investment Purchase and Sale $103.07M -$7.92M $27.50M -$361.56M -$143.01M
Financing Cash Flow $2.33M $7.52M $96.61M $478.05M $1.89M
Net Cash Flow from Continuing Financing Activities $2.33M $7.52M $96.61M $478.05M $1.89M
Net Issuance Payments Of Debt $0.00 $0.00 $93.89M $0.00 $0.00
Net Common Stock Issuance $0.00 $0.00 $0.00 $470.51M $0.00
Proceeds from Stock Option Exercised $2.33M $7.52M $3.54M $7.54M $1.89M
Net Other Financing Charges $0.00 $0.00 -$813,000.00 – –
Ending Cash Balance $219.97M $226.54M $294.98M $301.62M $301.62M
Net Change in Cash -$6.56M -$68.45M -$6.64M $11.51M $27.00M
Beginning Cash Balance $226.54M $294.98M $301.62M $290.11M $274.62M
Free Cash Flow -$111.96M -$68.51M -$130.75M -$360.05M -$87.02M

Discussion

No comments yet — be the first to weigh in on BEAM.

Sign in to join the discussion.

Scroll to Top